- Home
- RGS vs ATNM Comparison
RGS vs ATNM Comparison
Compare RGS & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGS
- ATNM
- Stock Information
- Founded
- RGS 1922
- ATNM 2000
- Country
- RGS United States
- ATNM United States
- Employees
- RGS N/A
- ATNM N/A
- Industry
- RGS Other Consumer Services
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- RGS Consumer Discretionary
- ATNM Health Care
- Exchange
- RGS Nasdaq
- ATNM Nasdaq
- Market Cap
- RGS 70.8M
- ATNM 50.2M
- IPO Year
- RGS 1991
- ATNM N/A
- Fundamental
- Price
- RGS $30.13
- ATNM $1.52
- Analyst Decision
- RGS
- ATNM Strong Buy
- Analyst Count
- RGS 0
- ATNM 2
- Target Price
- RGS N/A
- ATNM $4.50
- AVG Volume (30 Days)
- RGS 16.1K
- ATNM 143.4K
- Earning Date
- RGS 11-05-2025
- ATNM 11-13-2025
- Dividend Yield
- RGS N/A
- ATNM N/A
- EPS Growth
- RGS 20.23
- ATNM N/A
- EPS
- RGS 46.10
- ATNM N/A
- Revenue
- RGS $210,134,000.00
- ATNM N/A
- Revenue This Year
- RGS N/A
- ATNM N/A
- Revenue Next Year
- RGS N/A
- ATNM N/A
- P/E Ratio
- RGS $0.69
- ATNM N/A
- Revenue Growth
- RGS 3.52
- ATNM N/A
- 52 Week Low
- RGS $15.00
- ATNM $1.03
- 52 Week High
- RGS $31.50
- ATNM $2.41
- Technical
- Relative Strength Index (RSI)
- RGS 63.12
- ATNM 42.38
- Support Level
- RGS $28.74
- ATNM $1.47
- Resistance Level
- RGS $31.50
- ATNM $1.59
- Average True Range (ATR)
- RGS 0.96
- ATNM 0.07
- MACD
- RGS -0.15
- ATNM -0.00
- Stochastic Oscillator
- RGS 58.83
- ATNM 21.43
About RGS Regis Corporation
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.